Latest Fibrodysplasia ossificans progressiva Stories
MONTREAL, Dec. 1, 2014 /PRNewswire/ -- Clementia Pharmaceuticals, Inc. announced today that the U.S.
Researchers have developed a new way to study bone disorders and bone growth, using stem cells from patients afflicted with a rare, genetic bone disease.
Scientists have developed a new genetic approach to specifically block the damaged copy of the gene for a rare bone disease, while leaving the normal copy untouched.
For hundreds of thousands of people, injuring a muscle through an accident like falling off a bike or having surgery can result in a strange and serious complication.
PHILADELPHIA, April 3, 2011 /PRNewswire-USNewswire/ -- Promising new research reveals a potentially highly effective treatment for heterotopic ossification (HO), a painful and often debilitating abnormal buildup of bone tissue.
As debilitating as disease can be, finding paths that could possibly lead to a cure is quite rewarding.
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the bodyâ€™s skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.